"Ongoing analysis of manufacturing outcomes???" What exactly does that mean?? Does it mean they are not actively pushing the trial preparations forward but just analysing the manufactured PAT-SM6?
From Sept to Dec 2014 PAB spent (according to their 4C) $1.805M on R&D....this seems to have dropped to only $889k in the period Dec to March 2015. So, are they just spending less to conserve cash and keep the Company alive or are they really spending cash to actually get this trial started?? Some update and clarity would be nice with the stock price languishing around 1c for ages now!
PAB Price at posting:
1.1¢ Sentiment: None Disclosure: Not Held
